Mineralys Therapeutics, Inc.
MLYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $598 | $311 | $95 | $92 |
| - Cash | $114 | $49 | $88 | $11 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $483 | $262 | $8 | $81 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$192 | -$85 | -$31 | -$19 |
| % Margin | – | – | – | – |
| Net Income | -$178 | -$72 | -$30 | -$19 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.66 | -1.99 | -5.77 | -3.89 |
| % Growth | -83.9% | 65.5% | -48.3% | – |
| Operating Cash Flow | -$166 | -$81 | -$29 | -$15 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$166 | -$81 | -$29 | -$15 |